BAVENCIO
BAVENCIO
Approved
DIN Number
02469723
Drug Class
Human
Market Date
Dec 18, 2017
Company
HC
emd serono, a division of emd inc., canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02469723
AIG Number0159690001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FF04 AVELUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AVELUMABActive
Strength: 20 MG / ML
Monograph: AVELUMAB